1. Home
  2. SBR vs CERT Comparison

SBR vs CERT Comparison

Compare SBR & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sabine Royalty Trust

SBR

Sabine Royalty Trust

HOLD

Current Price

$75.13

Market Cap

1.0B

Sector

Energy

ML Signal

HOLD

CERT

Certara Inc.

HOLD

Current Price

$6.18

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBR
CERT
Founded
1982
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Retail: Computer Software & Peripheral Equipment
Sector
Energy
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
SBR
CERT
Price
$75.13
$6.18
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$12.22
AVG Volume (30 Days)
32.6K
3.3M
Earning Date
02-27-2026
05-04-2026
Dividend Yield
6.51%
N/A
EPS Growth
N/A
87.50
EPS
N/A
N/A
Revenue
N/A
$418,838,000.00
Revenue This Year
N/A
$4.26
Revenue Next Year
N/A
$5.40
P/E Ratio
$12.77
N/A
Revenue Growth
N/A
8.75
52 Week Low
$58.25
$6.04
52 Week High
$84.39
$15.38

Technical Indicators

Market Signals
Indicator
SBR
CERT
Relative Strength Index (RSI) 58.30 29.73
Support Level $65.77 $6.04
Resistance Level $79.86 $11.53
Average True Range (ATR) 1.92 0.34
MACD 0.06 -0.00
Stochastic Oscillator 69.05 5.23

Price Performance

Historical Comparison
SBR
CERT

About SBR Sabine Royalty Trust

Sabine Royalty Trust is an express trust which is formed to receive Sabine Corporation's royalty and mineral interests, including landowner's royalties, overriding royalty interests, minerals production payments and any other similar, non-participatory interests, in certain Royalty Properties. The trusts producing and proved undeveloped oil and gas royalty properties are located in Florida, Louisiana, Mississippi, New Mexico, Oklahoma, and Texas.

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.

Share on Social Networks: